Universität Wien

323109 VU Drug targets, hit discovery and case studies - MPS5 (2018S)

2.00 ECTS (1.00 SWS), SPL 32 - Pharmazie
Prüfungsimmanente Lehrveranstaltung

Details

Sprache: Englisch

Lehrende

Termine

Zur Zeit sind keine Termine bekannt.

Information

Ziele, Inhalte und Methode der Lehrveranstaltung

The course aims to provide students with an understanding of the thermodynamics of protein-ligand interaction and the contribution of the entropic term, the importance of drug like properties in drug discovery and strategies for identifying and validating new targets. These topics will be discussed on specific case studies concerning discovery of new medicines targeting nuclear receptors, kinases and proteases.
 Protein structure, Protein-ligand interactions (thermodynamics of the interaction, free energy, enthalpy, entropy).
 structure and function, physicochemical properties, lead-like properties, QSAR
 Target identification and validation: biochemical, pharmacological and genomic methodologies, (genetic engineering, transgenic animals, silencing genes, recombinant proteins, transcriptomics proteomics)
 Case studies in drug discovery. (nuclear receptors, kinases, proteases)

Art der Leistungskontrolle und erlaubte Hilfsmittel

One term paper on a drug target
A written examination on approaches to analog design (on June 26th)

Mindestanforderungen und Beurteilungsmaßstab

Prüfungsstoff

Literatur

• Basic Principles of Drug Discovery and Development by Benjamin Blass, Academic Press
• Drug Discovery and Development by Raymond Hill, Churchill Livingstone Elsevier
• Drug Design by Gerhardt Klebe, Springer
• Drug like properties: Concepts, Structure design and Methods by Edward H. Kerns and Li Di, Academic Press Elsevier

Zuordnung im Vorlesungsverzeichnis

Letzte Änderung: Fr 31.08.2018 08:43